JP2004535384A5 - - Google Patents

Download PDF

Info

Publication number
JP2004535384A5
JP2004535384A5 JP2002582950A JP2002582950A JP2004535384A5 JP 2004535384 A5 JP2004535384 A5 JP 2004535384A5 JP 2002582950 A JP2002582950 A JP 2002582950A JP 2002582950 A JP2002582950 A JP 2002582950A JP 2004535384 A5 JP2004535384 A5 JP 2004535384A5
Authority
JP
Japan
Prior art keywords
composition
polymer
serum glucose
glucose
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002582950A
Other languages
English (en)
Japanese (ja)
Other versions
JP4499363B2 (ja
JP2004535384A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/011493 external-priority patent/WO2002085377A1/en
Publication of JP2004535384A publication Critical patent/JP2004535384A/ja
Publication of JP2004535384A5 publication Critical patent/JP2004535384A5/ja
Application granted granted Critical
Publication of JP4499363B2 publication Critical patent/JP4499363B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002582950A 2001-04-18 2002-04-10 血清グルコースの減少方法 Expired - Lifetime JP4499363B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28444501P 2001-04-18 2001-04-18
US30556401P 2001-07-13 2001-07-13
PCT/US2002/011493 WO2002085377A1 (en) 2001-04-18 2002-04-10 Method for lowering serum glucose

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010009197A Division JP2010090172A (ja) 2001-04-18 2010-01-19 血清グルコースの減少方法

Publications (3)

Publication Number Publication Date
JP2004535384A JP2004535384A (ja) 2004-11-25
JP2004535384A5 true JP2004535384A5 (enExample) 2005-12-22
JP4499363B2 JP4499363B2 (ja) 2010-07-07

Family

ID=26962623

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002582950A Expired - Lifetime JP4499363B2 (ja) 2001-04-18 2002-04-10 血清グルコースの減少方法
JP2010009197A Pending JP2010090172A (ja) 2001-04-18 2010-01-19 血清グルコースの減少方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010009197A Pending JP2010090172A (ja) 2001-04-18 2010-01-19 血清グルコースの減少方法

Country Status (17)

Country Link
US (2) US7229613B2 (enExample)
EP (1) EP1392331B1 (enExample)
JP (2) JP4499363B2 (enExample)
KR (1) KR20040018358A (enExample)
CN (1) CN1511039A (enExample)
AT (1) ATE390927T1 (enExample)
AU (1) AU2002257145B2 (enExample)
BR (1) BRPI0209134B8 (enExample)
CA (1) CA2444046C (enExample)
CY (1) CY1119486T1 (enExample)
DE (1) DE60225908T2 (enExample)
DK (2) DK1392331T3 (enExample)
ES (2) ES2637020T3 (enExample)
MX (1) MXPA03009568A (enExample)
NZ (1) NZ528831A (enExample)
PT (1) PT1923064T (enExample)
WO (1) WO2002085377A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
CA2444046C (en) * 2001-04-18 2011-06-07 Steven K. Burke Use of colesevelam in reducing serum glucose
US7220406B2 (en) * 2002-10-22 2007-05-22 Genzyme Corporation Method for promoting bone formation
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7335795B2 (en) * 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
WO2005092349A1 (ja) * 2004-03-26 2005-10-06 Mitsubishi Pharma Corporation インスリン抵抗性改善剤
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
EP1830832A1 (en) * 2004-12-30 2007-09-12 Genzyme Corporation Zinc-containing treatments for hyperphosphatemia
WO2007027566A2 (en) * 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
CA2622693C (en) 2005-09-15 2015-05-05 Genzyme Corporation Sachet formulation for amine polymers
JP2009514966A (ja) * 2005-11-08 2009-04-09 ジェンザイム・コーポレーション 高リン血症のためのマグネシウム含有重合体
WO2008005217A2 (en) * 2006-07-05 2008-01-10 Genzyme Corporation Iron(ii)-containing treatments for hyperphosphatemia
WO2008062437A2 (en) * 2006-09-01 2008-05-29 Usv Limited Process for the preparation of sevelamer hydrochloride and formulation thereof
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
EP2361171A4 (en) * 2008-09-15 2014-11-05 Shasun Chemicals And Drugs Ltd PROCESS FOR PREPARING NETWORKED POLYMERS IN A NON-AQUEOUS SOLUTION
US20110081413A1 (en) * 2009-01-22 2011-04-07 Ashok Omray Pharmaceutical Compositions Comprising Phosphate-Binding Polymer
US9566299B2 (en) 2013-02-08 2017-02-14 Wockhardt Limited Oral pharmaceutical composition of aliphatic amine polymer or salts thereof
PE20151766A1 (es) * 2013-03-15 2015-12-11 Genzyme Corp Agentes quelantes de precursores de producto final de glicacion avanzada (age)
ES2908142T3 (es) 2014-06-13 2022-04-27 United Therapeutics Corp Formulaciones de treprostinil
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
JP6792640B2 (ja) 2016-12-28 2020-11-25 富士フイルム株式会社 窒素原子含有ポリマー又はその塩の乳化液、その製造方法、及び粒子の製造方法
EP3698799B1 (en) 2017-10-16 2022-01-26 FUJIFILM Corporation Hyperphosphatemia treatment agent
ES2980624T3 (es) 2021-08-24 2024-10-02 Waterstone Pharmaceuticals Wuhan Co Ltd Polímeros, composiciones y métodos para tratar hiperuricemia
WO2023023938A1 (en) * 2021-08-24 2023-03-02 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Polymers, compositions and methods for treating hyperuricemia

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4528847A (en) * 1983-10-04 1985-07-16 D. Halmi And Associates, Inc. Flow metering device with recessed pressure taps
JPS6090243A (ja) 1983-10-25 1985-05-21 Nitto Boseki Co Ltd 小球状モノアリルアミン橋かけ重合体の製造方法
CA1220896A (en) 1983-11-10 1987-04-21 Susumu Harada Process for producing polymers of monoallylamine
US5468727A (en) * 1990-12-13 1995-11-21 Board Of Regents, The University Of Texas System Methods of normalizing metabolic parameters in diabetics
JP3507523B2 (ja) 1993-05-12 2004-03-15 積水化学工業株式会社 糖質吸収抑制剤
US5487888A (en) 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
US5618530A (en) 1994-06-10 1997-04-08 Geltex Pharmaceuticals, Inc. Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5607669A (en) 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5900475A (en) 1994-06-10 1999-05-04 Geltex Pharmaceuticals, Inc. Hydrophobic sequestrant for cholesterol depletion
US5624963A (en) 1993-06-02 1997-04-29 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5703188A (en) 1993-06-02 1997-12-30 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
TW474813B (en) 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
JP4156684B2 (ja) * 1996-03-05 2008-09-24 三菱化学株式会社 高リン血症予防および/または治療剤
US6203785B1 (en) 1996-12-30 2001-03-20 Geltex Pharmaceuticals, Inc. Poly(diallylamine)-based bile acid sequestrants
US5925379A (en) 1997-03-27 1999-07-20 Geltex Pharmaceuticals, Inc. Interpenetrating polymer networks for sequestration of bile acids
TW592727B (en) 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
US6423754B1 (en) 1997-06-18 2002-07-23 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with polyallylamine polymers
FR2766195A1 (fr) 1997-07-21 1999-01-22 Transgene Sa Polymeres cationiques, complexes associant lesdits polymeres cationiques et des substances therapeutiquement actives comprenant au moins une charges negative, notamment des acides nucleiques, et leur utilisation en therapie genique
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
US5985938A (en) 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6083497A (en) 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
WO1999040990A1 (en) 1998-02-17 1999-08-19 University Of Maryland Anion binding polymers and the use thereof
DK1140185T3 (da) * 1998-12-23 2003-09-29 Searle Llc Kombinationer af cholesterylestertransferhæmmere og galdesyre kompleksdannende forbindelser til hjertekar indikationer
AU7856200A (en) * 1999-10-07 2001-05-10 University Of Maryland Sugar binding polymers and the use thereof
TWI241195B (en) * 2000-04-10 2005-10-11 Shionogi & Co Preventive agent for bile acidic diarrhea
CA2444046C (en) * 2001-04-18 2011-06-07 Steven K. Burke Use of colesevelam in reducing serum glucose
US20020198202A1 (en) 2001-06-07 2002-12-26 Wyeth Combination of a PTPase inhibitor and an antilipemic agent

Similar Documents

Publication Publication Date Title
JP2004528332A5 (enExample)
CA2444046A1 (en) Use of colesevelam in reducing serum glucose
US7919182B2 (en) Pressure-sensitive adhesive sheet for application to skin
EP0680754B1 (en) Percutaneous absorption preparation containing Buprenorphine
CA2481365A1 (en) Occlusive composition comprising a poly (2-cyanoacrylate) monomer
JP2004520473A5 (enExample)
JP2008518949A5 (enExample)
JP2003113113A5 (enExample)
JP2020506919A5 (enExample)
CA1237229A (en) Method for making conductive member for skin contact electrode containing sulfonated polymer material
JP2002543065A5 (enExample)
CA2309004A1 (en) Adhesive composition and method for producing it
ATE253900T1 (de) Wässrige dispersion geeignet zur herstellung von überzugs- und bindemitteln für feste orale arzneiformen
WO2004083280A8 (en) Polyamide-polyether block copolymer
JP2005538035A5 (enExample)
RU2000124095A (ru) Звездообразный полимер-модификатор индекса вязкости для композиций масел и композиции масел с ним
EP0187844A4 (en) FERROUS POLYMERIC CHELATING AGENTS.
JP2023531444A5 (enExample)
FI3793587T3 (fi) PTH-konjugaattien aloitusannos
JP2020518685A5 (enExample)
CN111905155B (zh) 一种封闭水凝胶及其制备方法和应用
CA2338854A1 (en) Nitric esters and nitrate salts of specific drugs
JP2004532301A5 (enExample)
CA2286091A1 (en) Polymer-platinum compounds
CA2509074A1 (en) A catalytic composition and its preparation and use for preparing polymers from ethylenically unsaturated monomers